| pubmed-article:7301695 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7301695 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7301695 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:7301695 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:7301695 | pubmed:issue | 670 | lld:pubmed |
| pubmed-article:7301695 | pubmed:dateCreated | 1982-1-28 | lld:pubmed |
| pubmed-article:7301695 | pubmed:abstractText | Pituitary function was assessed in 39 patients with previously untreated hyperprolactinaemia. Primary hypothyroidism, drug-induced hyperprolactinaemia and chronic renal failure were excluded in all patients. All of the 22 patients (group 1), who had either a normal pituitary fossa or a minor radiological change on lateral skull X-ray, had completely normal pituitary function with the exception of 2 who were partially growth hormone-deficient. However, 9 of the 17 patients with macroadenomas (group 2) had a deficit of one or more anterior pituitary hormones. After the lateral skull X-ray 13 patients in group 1 had further neuroradiological investigations. In only one was a minor abnormality noted which had not been observed on the plain film and this was not of practical significance. In centres where hyperprolactinaemic patients with a normal pituitary fossa or a minor radiological change on lateral skull X-ray are treated with bromocriptine, further neuroradiological investigations and dynamic tests of pituitary function are not required. | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7301695 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7301695 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7301695 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7301695 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:7301695 | pubmed:issn | 0032-5473 | lld:pubmed |
| pubmed-article:7301695 | pubmed:author | pubmed-author:BeardwellC... | lld:pubmed |
| pubmed-article:7301695 | pubmed:author | pubmed-author:ShaletS MSM | lld:pubmed |
| pubmed-article:7301695 | pubmed:author | pubmed-author:ChapmanA JAJ | lld:pubmed |
| pubmed-article:7301695 | pubmed:author | pubmed-author:WhiteheadEE | lld:pubmed |
| pubmed-article:7301695 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7301695 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:7301695 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7301695 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7301695 | pubmed:pagination | 485-7 | lld:pubmed |
| pubmed-article:7301695 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:meshHeading | pubmed-meshheading:7301695-... | lld:pubmed |
| pubmed-article:7301695 | pubmed:year | 1981 | lld:pubmed |
| pubmed-article:7301695 | pubmed:articleTitle | A practical approach to the investigation of the hyperprolactinaemic patient. | lld:pubmed |
| pubmed-article:7301695 | pubmed:publicationType | Journal Article | lld:pubmed |
